Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy

Cannon, Christopher P., Steinberg, Benjamin A., Murphy, Sabina A., Mega, Jessica L., Braunwald, Eugene·2006·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2006.04.070

Cited by (772)

Items 401–500 of 772

Impact of Lipid-Lowering Therapy on Mortality According to the Baseline Non-HDL Cholesterol Level: A Meta-Analysis
Walter M. Masson, Martín Lobo, Daniel Alberto Siniawski, Graciela B. Molinero, Melina S. Huerin, Juan Patricio Nogueira · 2019 · High Blood Pressure & Cardiovascular Prevention
Effects of intensive pitavastatin therapy on glucose control in patients with non-ST elevation acute coronary syndrome.
Yanbo Wang, Xianghua Fu, Xinshun Gu, Weize Fan, Yunfa Jiang, Guozhen Hao, Qing Miao, Jie Jane Cao, Bing Fu, Yi Li · 2017 · Europe PMC (PubMed Central)
Research advances in current drugs targeting hyperlipidemia (Review)
Hanwei Zhao, Yao Wang, Yaqing Li, Ran Cheng, Wenge Chen · 2025 · Molecular Medicine Reports
Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain
Juan Cosı́n-Sales, Eduard Sidelnikov, Santiago Villamayor, Miriam Fernández, Sandra Merino-Montero, Alberto Zamora · 2022 · Advances in Therapy
Statins and the “Healthy User Bias” in Cardiac Surgery
William Scott Beattie, Duminda Nalaka Wijeysundera · 2010 · Anesthesia & Analgesia
Changes in coronary plaque morphology in patients with acute coronary syndrome versus stable angina pectoris after initiation of statin therapy
Amy L. Gin, Rocco Vergallo, Yoshiyasu Minami, Daniel Ong, Jingbo Hou, Haibo Jia, Tsunenari Soeda, Sining Hu, Shaosong Zhang, H Lee et al. · 2016 · Coronary Artery Disease
Prognostic performance of coronary computed tomography angiography in asymptomatic individuals as compared to symptomatic patients with an appropriate indication
Gabriel Camargo, Thais Peclat, Ana Carolina Souza, Ronaldo de Souza Leão Lima, Ilan Gottlieb · 2017 · Journal of cardiovascular computed tomography
Association of statin therapy with clinical outcomes in patients with vasospastic angina: Data from Korean health insurance review and assessment service
So Jin Park, Hye‐Jeong Park, Danbee Kang, Taek Kyu Park, Jinkyeong Park, Joongbum Cho, Chi Ryang Chung, Kyeongman Jeon, Eliseo Güallar, Juhee Cho et al. · 2019 · PLoS ONE
Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable and acute coronary heart disease in the United Arab Emirates
Wael A. Almahmeed, Sherif Bakir, Salem Beshyah, Bassem Morcos, Sameh Wajih, Martin Horack, Dominik Lautsch, Baishali M. Ambegaonkar, Philippe Brudi, Carl A. Baxter et al. · 2019 · Heart Views
Low‐density lipoprotein cholesterol reduction and target achievement after switching from statin monotherapy to statin/ezetimibe combination therapy: Real‐world evidence
Jeongmin Lee, Sue Hyun Lee, Hyunah Kim, Seung‐Hwan Lee, Jae‐Hyoung Cho, H. Lee, Hyeon Woo Yim, Kun‐Ho Yoon, Hun‐Sung Kim, Ju Han Kim · 2020 · Journal of Clinical Pharmacy and Therapeutics
Risk Profile for Cardiovascular Morbidity and Mortality After Lung Transplantation
Annette De Vito Dabbs, Mi‐Kyung Song · 2008 · Nursing Clinics of North America
ST Segment Elevation Acute Myocardial Infarction and Complications of Myocardial Infarction
Jeffrey L. Anderson · 2012 · Elsevier eBooks
Effect of β-hydroxy-β-methylglutaryl coenzyme a reductase inhibitors and antioxidant vitamins on free radical lipid oxidation in rat liver
Vadim Z. Lankin, Marina V. Ivanova, Коновалова Галина Георгиевна, Alla K. Tikhaze, А. И. Каминный, Valery V. Kukharchuk · 2007 · Bulletin of Experimental Biology and Medicine
A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets
Jean Lachaîne, Elizabeth P. Merikle, Jean‐Éric Tarride, Martin Montpetit, Stéphane Rinfret · 2007 · Clinical Therapeutics
Statin–Ezetimibe Combination Therapy In Diabetic Individuals
Theodosios D. Filippatos, Moses Elisaf · 2015 · Angiology
Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering
Seung‐Jae Joo · 2012 · Korean Circulation Journal
A Clinician's Perspective on Rating the Strength of Evidence in a Systematic Review
Craig Ian Coleman, Ripple Talati, Chris M. White · 2009 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy
Steven Simoens, Peter Sinnaeve · 2012 · Cardiovascular Drugs and Therapy
Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy
Zhao Wang, Xi‐Long Zheng, Zenan Jiang, Xiao‐Bo Liao, Shui‐Ping Zhao · 2017 · International Journal of Cardiology
Add-on ezetimibe treatment to low-dose statins vs medium-intensity statin monotherapy in coronary artery disease patients with poorly controlled dyslipidemia
Masashi Sakuma, Shigeru Toyoda, Ryouta Hashimoto, Hiroko Yazawa, Taiki Masuyama, Suguru Hirose, Ryutaro Waku, Hisashi Hasumi, Toshiyuki Numao, Shichiro Abe et al. · 2019 · Hypertension Research
Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels
Abhinav Grover, Mansi Oberoi, Harmeet Singh Rehan, Lalit Kumar Gupta, Madhur Yadav · 2020 · Cureus
Optimal low-density lipoprotein cholesterol target level in Korean acute myocardial infarction patients (<70 mg/dL vs. <55 mg/dL): Based on Korea acute myocardial infarction registry-National Institute of Health
Joon Ho Ahn, Youngkeun Ahn, Myung Ho Jeong, Ju Han Kim, Young Joon Hong, Doo Sun Sim, Min Chul Kim, Kyung Hoon Cho, Dae Yong Hyun, Seung Hun Lee et al. · 2021 · International Journal of Cardiology
Machine learning approaches to predict the 1-year-after-initial-AMI survival of elderly patients
Jisoo Lee, Sulyun Lee, W. Nick Street, Linnea A. Polgreen · 2022 · BMC Medical Informatics and Decision Making
The Role of Bile Acid Sequestrants in the Management of Type 2 Diabetes Mellitus
Om P. Ganda · 2010 · Metabolic Syndrome and Related Disorders
Lipid-independent pleiotropic effects of statins in the management of acute coronary coronary syndromes
Kausik Kumar Ray, Christopher Paul Cannon · 2007 · Current Treatment Options in Cardiovascular Medicine
Hybrids of coumarin–indole: design, synthesis and biological evaluation in Triton WR-1339 and high-fat diet induced hyperlipidemic rat models
Koneni V. Sashidhara, K. Bhaskara Rao, Ravi Sonkar, Ram K. Modukuri, Yashpal Singh Chhonker, Pragati Kushwaha, Hardik Chandasana, A. Khanna, Rabi Sankar Bhatta, Gitika Bhatia et al. · 2016 · MedChemComm
To switch (statins) or not to switch? That is the question
Vasilios Gabriel Athyros, Κωνσταντίνος Τζιόμαλος, Asterios I. Karagiannis, Dimitri P. Mikhailidis · 2010 · Expert Opinion on Pharmacotherapy
Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how?
Zhen-Vin Lee, Ho Lam · 2022 · AsiaIntervention
Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease—A Narrative Clinical Review
Nikolaos Velidakis, Panagiotis Stachteas, Evangelia Gkougkoudi, Christodoulos E. Papadopoulos, Nikolaos P. E. Kadoglou · 2024 · Pharmaceuticals
Pharmacotherapy of dyslipidemias in the adult population
Giovanni Battista Vigna, R. Fellin · 2010 · Expert Opinion on Pharmacotherapy
Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials
Catarina Sternhufvud, Furio Colivicchi, Sanjay K Gandhi · 2015 · ClinicoEconomics and Outcomes Research
Task Force on Practice Guidelines A Report of the American College of Cardiology Foundation/American Heart Association 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction:
David Xiao-Ming Zhao, Jan Radford, Jacqueline E. Tamis‐Holland, Carl L. Tommaso, Cynthia M. Tracy, Jane A. Linderbaum, David A. Morrow, Laura Kristin Newby, Joseph P. Ornato, Francis M. Fesmire et al. · 2014
Statins and myocardial infarction: Type, dose, and administration time: Does it matter?
Νικόλαος Παπαγεωργίου, Effimia Maria Zacharia, Αlexandros Briasoulis, Emmanuel S. Androulakis, Dimitris Tousoulis · 2016 · Trends in Cardiovascular Medicine
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real‐Life Setting
Julien Bezin, Olaf H. Klungel, R. Lassalle, Caroline Dureau‐Pournin, Nicholas D Moore, Antoine Pariente · 2017 · Clinical Pharmacology & Therapeutics
Prevalence of lipid abnormalities and cholesterol target value attainment in Egyptian patients presenting with an acute coronary syndrome
Mohamed Ahmed Sobhy, Adel El Etriby, Amany El Nashar, Sameh Wajih, Martin Horack, Philippe Brudi, Dominik Lautsch, Baishali M. Ambegaonkar, Ami Vyas, Anselm Kai Gitt · 2018 · The Egyptian Heart Journal
Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
Nuntakorn Thongtang, Jirasak Piyapromdee, Natthakan Tangkittikasem, Kittichai Samaithongcharoen, Nithiwat Srikanchanawat, Sutin Sriussadaporn · 2020 · Diabetes Metabolic Syndrome and Obesity
Niveles plasmáticos de apolipoproteínas en una población saludable de la Argentina: implicaciones en prevención cardiovascular
Daniel Alberto Siniawski, Walter M. Masson, Ignacio Martin Bluro, Patricia Beatriz Sorroche, Walter Scordo, Juan G. Krauss, Arturo M. Cagide · 2025 · Revista Argentina de Cardiología
Wytyczne ESC dotyczące cukrzycy, stanu przedcukrzycowego i chorób układu sercowo- -naczyniowego opracowane we współpracy z EASD
ESC EASD · 2013 · Kardiologia Polska
Management Protocols of stable coronary artery disease in India: Executive summary
Sundeep Mishra, Saumitra Ray, Jamshed J Dalal, Jitendra P. S. Sawhney, Sivasubramanian Ramakrishnan, Tiny Nair, S. Iyengar, Vinay Kumar Bahl · 2016 · Indian Heart Journal
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization
Stefano Albani, Enrico Fabris, Sara Doimo, Giulia Barbati, Andrea Perkan, Marco Merlo, Giuseppe Gatti, Andrea Di Lenarda, Arnoud W.J. van ’t Hof, Patrizia Maras et al. · 2018 · European Heart Journal - Cardiovascular Pharmacotherapy
New insights in preventive cardiology and cardiac rehabilitation
Barry A. Franklin, Justin E. Trivax, Thomas E. Vanhecke · 2008 · Current Opinion in Cardiology
Atheroma Volume by Intravascular Ultrasound as a Surrogate for Clinical End Points
Jonathan M. Tobis, Alice Perlowski · 2009 · Journal of the American College of Cardiology
The Year in Atherothrombosis
Javier Sanz, Pedro Moreno, Valentı́n Fuster · 2007 · Journal of the American College of Cardiology
Combination of ezetimibe and garlic reduces serum lipids and intestinal niemann-pick C1-like 1 expression more effectively in hypercholesterolemic mice
Mohammadi, Abbas, Vafaei, Seyyed Alireza, Nabi Moradi, Mohammad, Ahmadi, Mehrdad, Pourjafar, Mona, Abbasi Oshaghi, Ebrahim · 2015 · Avicenna Journal of Medical Biochemistry
Short-Course High-Intensity Statin Treatment during Admission for Myocardial Infarction and LDL-Cholesterol Reduction—Impact on Tailored Lipid-Lowering Therapy at Discharge
Víctor Marcos‐Garcés, Hector Merenciano-Gonzalez, María Luz Martínez Mas, Patricia Palau, Josefa Inés Climent Alberola, Nerea Perez, Laura López, María Concepción Esteban Argente, María Valls Reig, Raquel Muñoz Alcover et al. · 2023 · Journal of Clinical Medicine
Cholesterol Levels and the Association of Statins With In‐Hospital Mortality of Myocardial Infarction Patients Insights From a Chilean Registry of Myocardial Infarction
Gonzalo Martínez, Attilio Rigotti, Mónica Acevedo B, Carlos Navarrete, Juanita Rosales, Robert Patrick Giugliano, Ramon L. Corbalan · 2013 · Clinical Cardiology
Frequency of Intensive Statin Therapy in Patients With Acute Coronary Syndrome Admitted to a Tertiary Care Center
Jennifer R. Shiu, Glen J. Pearson, Theresa L. Charrois, Gabor T. Gyenes, Sheri L. Koshman · 2011 · The American Journal of Cardiology
RELEVANCIA CLÍNICA DEL TRATAMIENTO FARMACOLÓGICO COMPLETO PRECOZ EN EL PRONÓSTICO DEL SÍNDROME CORONARIO AGUDO SIN ELEVACIÓN DEL ST
Elena Fortuny, Ivan Javier Nuñez-Gil, Juan Carlos García-Rubira, Borja Ruiz Mateos, Borja Ibáñez, Nieves Gonzalo, David Vivas Balcones, Carlos Macaya Miguel, Antonio Fernández‐Ortíz · 2011 · Emergencias
Is the Future of Statins Aligned with New Novel Lipid Modulation Therapies?
Binh An P. Phan, Peter Paul Toth · 2013 · Current Atherosclerosis Reports
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Endorsed by the American Association for Clinical Chemistry WRITING COMMITTEE MEMBERS*
Ezra A. Amsterdam, NANETTE KASS WENGER, Ralph G. Brindis, Donald E. Casey, Théodore G. Ganiats, David R. Holmes, Allan S. Jaffe, Hani M. Jneid, Rosemary F. Kelly, Michael Christopher Kontos et al. · 2014
Association Between Total Cholesterol and 5 year Mortality in Patients with Carotid Artery Stenosis and Poststroke Functional Dependence
Yen-Ju Lung, Wei‐Chieh Weng, Chia-Lun Wu, Wen‐Yi Huang · 2019 · Journal of Stroke and Cerebrovascular Diseases
Non-achievement of the Low-Density Lipoprotein Cholesterol Goal in Older Patients with Type 2 Diabetes Mellitus and a Very High Cardiovascular Disease Risk: A Multicenter Study in Vietnam
Huan Thanh Nguyen, Khang Pham Trong Ha, An Huu Nguyen, Thu Nguyen, Hang My Lam · 2021 · Annals of Geriatric Medicine and Research
Atherosclerosis Residual Lipid Risk-Overview of Existing and Future Pharmacotherapies
Muntaser Omari, Mohammad Alkhalil · 2024 · Journal of Cardiovascular Development and Disease
Real-life effectiveness of statins in the prevention of first acute coronary syndrome in France: A prospective observational study
Lamiae Grimaldi‐Bensouda, Michel Rossignol, Nicolas Danchin, Jean Dallongeville, Éric Bruckert, Jonathan Banayan, Yves Cottin, Elodie Aubrun, Artak Khachatryan, Jacques Bénichou et al. · 2013 · International Journal of Cardiology
Intensive Reduction of Low-Density Lipoprotein-Cholesterol
Daniel G. Hackam · 2006 · American Journal of Cardiovascular Drugs
Predictive Value of the Low-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio for the Prevention of Stroke Recurrence in Japanese Patients Treated with Rosuvastatin
Michiya Igase, Katsuhiko Kohara, Ryosuke Katagi, Shiro Yamashita, Mutsuo Fujisawa, Tetsuro Miki · 2012 · Clinical Drug Investigation
Aortic plaque regression as determined by magnetic resonance imaging with high-dose and low-dose statin therapy
Ilan Gottlieb, Sachin Agarwal, Sandeep Gautam, Milind Y. Desai, Henning Steen, William P Warren, Sérgio Salles Xavier, João A.C. Lima · 2008 · Journal of Cardiovascular Medicine
Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia
Arne Svilaas, Timo E. Strandberg, Mats Eriksson, Per Rossen Hildebrandt, Arne S. Westheim · 2008 · Scandinavian Cardiovascular Journal
Efficacy and safety of ezetimibe plus atorvastatin therapy
JoAnne Micale Foody, Peter Paul Toth, Andrew M. Tershakovec, Thomas Musliner, Joanne E. Tomassini, Robert S. Lowe, David Neff, Harry R. Davis · 2014 · Clinical Lipidology
Statins and beyond: Concurrent strategies for prevention of cardiovascular disease in patients with type 2 diabetes
Eberhard Standl · 2012 · Diabetes and Vascular Disease Research
Is lowering low-density lipoprotein an effective strategy to reduce cardiac risk?
H. Robert Superko, Spencer B. King · 2008
A comparison of secondary prevention practice in poststroke and coronary heart disease patients
Jiří Vaněk, Otto Mayer, Jitka Seidlerová, Jan Bruthans, Lenka Kielbergerová, Peter Wohlfahrt, Alena Krajčoviechová, Jan Filipovský, Renata Cífková · 2016 · Public Health
Lipid Management Guidelines from the Departments of Veteran Affairs and Defense: A Critique
Catherine S. Bennet, Chanukya Dahagam, Salim S. Virani, Seth Shay Martin, Roger Scott Blumenthal, Erin D. Michos, John William McEvoy · 2016 · The American Journal of Medicine
Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease
Falisha Adatia, Shannon Galway, Maja Grubisić, May Lee, Patrick Daniele, Karin H. Humphries, Tara Sedlak · 2017 · Journal of Women s Health
Clinical outcomes of PCSK9Is: a meta-analysis of randomized clinical trials
Rugheed Ghadban, Tariq H. Enezate, Jad Omran, Rajaa Almourani, Atul Singla, Sudarshan Balla · 2017 · Cardiovascular Diagnosis and Therapy
Contribution of aorta glycosaminoglycans and PCSK9 to hyperlipidemia in experimental rabbits: the role of 10-dehdrogingerdione as effective modulator
Mohamed Mahmoud Elseweidy, Sahar Elsayed El-Swefy, Nahla Nabil Younis, Shaden Tarek · 2019 · Molecular Biology Reports
Efficacy and Safety of High-intensity Statins in Patients With Acute Myocardial Infarction: An Asian Perspective
Po-Sheng Chen, Sheng‐Hsiang Lin, Cheng‐Han Lee, Hui‐Wen Lin, Yi‐Heng Li · 2019 · Canadian Journal of Cardiology
Pravastatin attenuates atherosclerosis after myocardial infarction by inhibiting inflammatory Ly6C high monocytosis in apolipoprotein E knockout mice
Yufei Chen, Hongqi Zhang, Liang Hu, Haiming Shi, Xiaojin Liu, Jianguo Jia, Shengjia Sun, Yang Ou, Xinping Luo, Guomin Zhou et al. · 2020 · Journal of International Medical Research
Appropriate Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Atherosclerotic Cardiovascular Disease: Comparison of Recommendations from Different Guidelines or Consensus Around the World.
Jia-Ling Lin, Po‐Hsun Huang, Hung‐I Yeh, Yi‐Heng Li · 2020 · PubMed Central
TRANSMUTATION OF METAL AT LOW ENERGY IN A CONFINED PLASMA IN WATER
Domenico Cirillo, V. Iorio · 2006 · International Conference on Condensed Matter Nuclear Science (ICCF)
Intensive statin therapy for Indians: Part-I. Benefits.
Enas A Enas, Hancy Chennikkara Pazhoor, Arun Thekkekarott Kuruvila, Krishnaswami Vijayaraghavan · 2011 · PubMed
Low-density lipoprotein lowering in type 2 diabetes mellitus: how to know how low to go
Allan D. Sniderman · 2007 · Current Opinion in Endocrinology Diabetes and Obesity
Benefits of intensive lipid-lowering therapies in patients with acute coronary syndrome: a systematic review and meta-analysis
Xian-Dan Wu, Xin-Yue Ye, Xuan-Yan Liu, Yue Lin, Xian Yong Lin, Yanyan Li, Bin-Hua Ye, Jing-Chao Sun · 2024 · Annals of Medicine
Design of VICTORION-2 Prevent: A randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease
Philippe Gabríel Steg, Shaun G. Goodman, J. Wouter Jukema, Pieter Martens, Andreas Zirlik, Deepak L. Bhatt, Venu Menon, Michael J. Szarek, Anastasia Lesogor, Christian Stratz et al. · 2026 · American Heart Journal
Awareness Among Primary Care Physicians in Canada of Guideline Recommendations for Lowering LDL-Cholesterol in High-Risk Patients
Zahra Taboun, Neil Naik, Vivien Brown, Peter Lin, Michelle Padarath, Robert Alexander Hegele, Milan Gupta · 2023 · CJC Open
Comparing High-Intensity Versus Low-to Moderate-Intensity Statin Therapy in Korean Patients with Acute Myocardial Infarction
Minah Kim, Hyun Kuk Kim, Youngkeun Ahn, Hyukjin Park, Myung Ho Jeong, Jeong Gwan Cho, Jong Chun Park, Young‐Jo Kim, Myeong‐Chan Cho, Chong Jin Kim et al. · 2014 · Journal of Lipid and Atherosclerosis
Modern algorithms for statin therapy
Andrey V. Susekov · 2023 · Russian Journal of Cardiology
Adjunctive Lipid Lowering Therapy in the Era of Surrogate Endpoints
Michael G. Silverman, Michael Joseph Blaha, Roger Scott Blumenthal · 2010 · Cardiology in Review
ST-Segment Elevation Myocardial Infarction
Frederick G. Kushner, Eric Bates · 2012 · Elsevier eBooks
Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia
Saud Al Sifri, Owayed Al Shammeri, Saleh Al Jaser, Abdullah Hamad Alkhenizan, Atif Bin Shafi Shafiurrehman, Bassem Morcos, Sameh Wajih, Ibrahim Elnahal, Martin Horack, Philippe Brudi et al. · 2018 · Saudi Medical Journal
Lipids: a personal view of the past decade
Niki Katsiki, Dimitri P. Mikhailidis · 2018 · HORMONES
Factors Associated With Coronary Artery Disease Progression Assessed By Serial Coronary Computed Tomography Angiography
Gabriel Camargo, Tamara Rothstein, Maria Eduarda Derenne, Letícia Roberto Sabioni, João A.C. Lima, Ronaldo de Souza Leão Lima, Ilan Gottlieb · 2017 · Arquivos Brasileiros de Cardiologia
Administración de estatinas durante la fase aguda del síndrome coronario agudo
Manuel Ruiz-Bailén · 2009 · Medicina Intensiva
INTERNATIONAL HEALTH NEWS
William R. Ware · 2010
The Great Debate of 2008—How Low to Go in Preventive Cardiology?
Eric David Peterson · 2008 · JAMA
The current role of statins in acute coronary syndrome
Amit Kumar, Christopher Paul Cannon · 2008
Defining the Role of High-Dose Statins in PCI
Giacinta Guarini, Mario Marzilli · 2013 · American Journal of Cardiovascular Drugs
Consensus statement on the management of dyslipidaemias in adults
Sophie Béliard, Fabrice Bonnet, Béatrice Bouhanick, Éric Bruckert, Bertrand Cariou, Sybil Charrière, Vincent Durlach, Philippe Moulin, René Valéro, Bruno L Vergès · 2017 · Annales d Endocrinologie
A Retrospective Study on the Adoption of Lipid Management Guidelines in Post-Myocardial Infarction Patients in a Tertiary Care Centre
Patricia M Wambua, Zahid Ullah Khan, Charles M Kariuki, Elijah Nyainda Ogola · 2023 · Cureus
Is a statin as part of a polypill the answer?
Jennifer G. Robinson · 2008 · Current Atherosclerosis Reports
Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patients
Michel Farnier, William V. Taggart, Qian Dong, Jianxin Lin, Arvind Kumar Shah, Philippe Brudi · 2011 · Journal of clinical lipidology
Dyslipidemia: Pathogenesis and Management
Om P. Ganda · 2009 · Springer eBooks
Short-term therapy with high dose atorvastatin in patients with coronary artery disease can reduce inflammatory process.
Vida Nesar Hossein, Keivan Yosef Nejad, Fatemeh Abdollahi · 2010 · PubMed
Anticoagulants in ischemia-guided management of non-ST-elevation acute coronary syndromes
Martin G. Mayer · 2017 · The American Journal of Emergency Medicine
Management of Dyslipidemia
Peter Paul Toth · 2010 · Humana Press eBooks
The interaction of dyslipidaemia with glycaemia in an adult population study
Sarah Cuschieri, Josanne Vassallo, Neville Calleja, Christopher Barbara, Julian Alexander Mamo · 2018 · Journal of Diabetes & Metabolic Disorders
Rationale for aggressive lipid lowering in high-risk patients.
Jerome D. Cohen · 2011 · PubMed
Comparative effect of statins and types of physical exercise on arterial stiffness
Vicente Martínez‐Vizcaíno, Iván Cavero‐Redondo, Alicia Saz‐Lara, Diana P. Pozuelo‐Carrascosa, Blanca Notario‐Pacheco, Manuel Ángel Gómez-Marcos, Celia Álvarez‐Bueno · 2019 · Medicine
Sustained low‐density lipoprotein‐cholesterol <70 mg/dl is associated with improved cardiovascular outcomes in the clinical setting
Carmen Sánchez‐Bacaicoa, Javier Galán, Carlos Guijarro, Sergio Rico‐Martín, Manuel Monréal, Julián Fernando Calderón García, Eduardo Aguilar‐Cortés, Juan Francisco Sánchez Muñoz-Torrero, for FRENA Investigators · 2021 · European Journal of Clinical Investigation
Efficacy and Safety of Ezetimibe for Japanese Patients with Dyslipidaemia
Yasunori Sawayama, Shinji Maeda, Hachiro Ohnishi, Shin Hayashi, Jun Hayashi · 2010 · Clinical Drug Investigation